Bacterial extracellular microenvironment

The target described as "Multiple Gram-positive bacteria via extracellular microenvironment alteration" refers to a therapeutic strategy that inhibits bacterial growth by modifying the chemical or physical conditions of the bacterial surroundings. Rather than binding to a specific protein or enzyme, drugs hitting this target alter factors such as local pH, ion concentrations, or the presence of reactive chemical species to create an environment lethal to various Gram-positive pathogens. For example, the drug methenamine is hydrolyzed in acidic urine to release formaldehyde, a non-specific antimicrobial, while probiotics like Lactobacillus produce lactic acid to lower the pH of the vaginal or skin microenvironment. Newer agents like XF-73 (exeporfinium chloride) are thought to disrupt the bacterial cell membrane and the immediate extracellular environment, leading to rapid cell death across a broad spectrum of Gram-positive species. This approach is advantageous for its broad-spectrum activity and low potential for the development of traditional molecular resistance, although it requires careful management of local conditions and potential effects on the host's commensal flora.

Other names

Bacterial microenvironmentExtracellular nicheBacterial extracellular matrixLocal antimicrobial environment

Alteration of the local chemical or physical environment (e.g., pH reduction, release of non-specific biocides like formaldehyde or reactive oxygen species) to inhibit the growth and survival of multiple Gram-positive bacterial species.